3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Gastrointestinal
2
Breast
2
Gynecologic
1
Genitourinary
1
Conditions
Breast Neoplasms
104
Neoplasms
13
Neoplasm Metastasis
8
Sarcoma
6
Pancreatic Neoplasms
6
Ovarian Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Melanoma
5
Leukemia, Myeloid, Acute
5
Colorectal Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Squamous Cell Carcinoma of Head and Neck
4
Prostatic Neoplasms
4
Lung Neoplasms
4
Liposarcoma
4
Multiple Myeloma
3
Head and Neck Neoplasms
3
Glioblastoma
3
Endometrial Neoplasms
3
Colonic Neoplasms
3
Breast Diseases
3
Brain Neoplasms
3
Triple Negative Breast Neoplasms
2
Recurrence
2
Neoplasm, Residual
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Inflammation
2
Estrogen Receptor-positive Breast Cancer
2
Esophageal Squamous Cell Carcinoma
2
Interventions
Exercise
5
Vitamin D
3
Resistance Training
3
Ascorbic Acid
3
salicylsalicylic acid
2
palbociclib
2
epigallocatechin gallate
2
Tea
2
Tablets
2
Surgical Procedures, Operative
2
Sufentanil
2
Spironolactone
2
Oxycodone
2
Omeprazole
2
Nutrition Assessment
2
Morphine
2
Metformin
2
Ketorolac
2
Infliximab
2
Ibuprofen
2
Fish Oils
2
Endurance Training
2
Dexmedetomidine
2
Blood Specimen Collection
2
Aspirin
2
ziprasidone
1
soybean oil, phospholipid emulsion
1
semaglutide
1
montelukast
1
microcrystalline cellulose
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Inflammation
×
palbociclib
×
Clear all
NCT06307249
2024-03-12
PTST_PALBEVA
Lebanese University
Phase 1
Recruiting
50 enrolled
NCT06065592
2023-10-06
CAT_PB
Lebanese University
Phase 1
Unknown
500 enrolled